Abstract
<b>Background:</b> Malignant pleural mesothelioma (MPM) is a rare malignancy with a poor prognosis. Pleurectomy/decortication (P/D) and extrapleural pneumonectomy (EPP) have been proposed for the surgical treatment of MPM with the goal of macroscopic complete resection (MCR). <b>Aim:</b> We reviewed the available literature on patients with MPM undergoing either EPP or P/D. <b>Methods:</b> A literature search was performed in three databases from 1980 to 2022. The 30 and 90-days mortality, the median overall survival (OS), the MCR rate, and the 1-, 2-, 3-, 5-year survival were the primary endpoints. The complications were the secondary endpoints. A fixed and a random effect model were used, appropriately. The <i>Q</i> statistic and <i>I<sup>2</sup></i> statistic were used to assess the heterogeneity among studies. Sensitivity analysis was performed including only studies incorporating the MCR concept. <b>Results:</b> We included eighteen studies with 4,852 patients (kappa=0.972; 95% CI: 0.917, 1.000). The 30-day mortality was higher in the EPP group (OR:2.79 [95% CI:1.30, 6.01]; p=0.009). The OS was increased in the P/D group (WMD:-4.55 [-6.05, -3.04]; p<0.001). No significant differences were found regarding the 90-day mortality, the MCR rate, and the 1-,2-,3-,5-year survival. These findings were further validated by the sensitivity analysis. The incidence of postoperative atrial fibrillation, hemorrhage, bronchopleural fistula, pulmonary embolism, air leak, and reoperation was higher in the EPP group (<i>p</i><0.05). <b>Conclusion:</b> P/D is associated with enhanced outcomes and should be preferred with the goal of MCR when technically feasible.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.